Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada and the state of Utah, United States. Its properties include Jubilee Mountain, Falcon and Paradox Basin. It owns a 100% interest in two barium sulphate (barite) projects, including the Frances Creek and Pedley Mountain property. It holds interests in a high-grade iodine, lithium, and bromine brine project situated in Utah, United States. It owns a 100% interest in two battery mineral projects that is focused on copper/zinc development. Its pipeline products include SmoothX 2.0%, MultiX Thick, MultiX Thin, HDX, LDX, VY-101 and VY-103.


TSXV:VM - Post by User

Comment by biggdoggon Jan 31, 2023 2:28pm
137 Views
Post# 35257483

RE:The next news will bring the price over 0,10

RE:The next news will bring the price over 0,10Much higher, They disclosed they are seeking Frances Creek Financing, Based on PEA, when this financing is announced, the $344M valuation should become reality. I am betting that this will take time. They have 133M shares out, take 50% of PEA = $1.30/share. This is reality, this is coming once the project is financed, if not higher. They have financing news coming, new carbon drug with RC, barium contrast sales, and FDA in the pipeline. This stock should be at over $0.50 by now for goodness sakes. Domestic production for radiology drugs as we head into WW3, Hard to believe this is still at the same price as when they proved up their unique resource back in 2017.  The smart money is accumulating these shares, this is on the verge of a major correction to where it should be valued.
<< Previous
Bullboard Posts
Next >>